2024 annual financial data
Janux Therapeutics 2024 Net margin
Direct answer
Net margin was -651.62%.
Operating income was -98,847,000 USD and net income was -68,994,000 USD.
Operating cash flow was Not available.
Get free Janux Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,588,000 USD
- Operating income
- -98,847,000 USD
- Net income
- -68,994,000 USD
- Operating cash flow
- Not available